KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Acquisitions (2019 - 2021)

Biolife Solutions (BLFS) reported Acquisitions of $1.5 million for Q3 2021, up 203.2% year-over-year from $500000.0 in Q3 2020, and down 89.51% on a QoQ basis from $14.4 million in Q4 2020.

Biolife Solutions (BLFS) has 3 years of Acquisitions data on file, last reported at $1.5 million in Q3 2021.

  • Quarterly Acquisitions rose 203.2% year-over-year to $1.5 million in Q3 2021, while the trailing twelve-month figure through Dec 2022 was $1.5 million (down 90.79% YoY) and the FY2021 annual result came in at $1.6 million, down 89.57% from the prior year.
  • Acquisitions declined to $1.5 million in Q3 2021 per BLFS's latest filing, from $14.4 million in the prior quarter.
  • Across five years, Acquisitions topped out at $14.4 million in Q4 2020 and bottomed at -$13.7 million in Q3 2019.
  • The 3-year median for Acquisitions is $1.3 million (2019), against an average of $804800.0.
  • Peak annual rise in Acquisitions reached 1054.84% in 2020, while the deepest fall reached 103.65% in 2020.
  • Tracing BLFS's Acquisitions over 3 years: stood at $1.3 million in 2019, then surged by 1054.84% to $14.4 million in 2020, then tumbled by 89.51% to $1.5 million in 2021.
  • Per Business Quant, the three latest BLFS Acquisitions figures stand at $1.5 million (Q3 2021), $14.4 million (Q4 2020), and $500000.0 (Q3 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 528.20 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 24.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 18.96 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 1.52 Mn
Dec 31, 2020 14.45 Mn
Sep 30, 2020 500,000.00
Dec 31, 2019 1.25 Mn
Sep 30, 2019 -13.69 Mn